Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA)


$0.2573
+0.0083 ( +0.90% ) 124.2K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$0.2573

Previous close


$0.2490

Volume


124.2K

Market cap


$12.79M

Day range


$0.2430 - $0.2600

52 week range


$0.2212 - $2.6250

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Feb 16, 2024
8-k 8K-related 12 Jan 19, 2024
3 Insider transactions 2 Jan 03, 2024
4 Insider transactions 1 Jan 03, 2024
4 Insider transactions 1 Jan 03, 2024
8-k 8K-related 19 Dec 20, 2023
4 Insider transactions 1 Dec 20, 2023
4 Insider transactions 1 Dec 18, 2023
8-k 8K-related 13 Dec 14, 2023

Latest News